Location History:
- Oxnard, CA (US) (1992)
- Brookline, MA (US) (2011)
- Boston, MA (US) (2017 - 2021)
- Newton, MA (US) (2022)
Company Filing History:
17 out of 20 
1 out of 237 
1 out of 1,373 
Years Active: 1992-2025
Title: A Spotlight on Innovator David E. Anderson
Introduction
David E. Anderson, an accomplished inventor based in Boston, MA, boasts an impressive portfolio of 16 patents. His innovative work primarily focuses on the development of vaccine compositions for various viral infections, showcasing his commitment to advancing medical biotechnology.
Latest Patents
Among his notable recent inventions is a patent for vaccine compositions designed for the treatment of coronavirus. This invention entails compositions and methods that offer preventive and therapeutic solutions for coronavirus infections. The composition is based on the development of immunogenic components, specifically virus-like particles (VLPs) that encompass key proteins from the Moloney Murine leukemia virus (MMLV) alongside viral epitopes from the SARS-CoV-2 spike protein.
Another significant patent developed by Anderson addresses the treatment of cytomegalovirus (HCMV) infections. This invention provides compositions and methods that leverage immunogenic approaches, again utilizing virus-like particles (VLPs). These include MMLV core proteins and HCMV epitopes, such as envelope glycoproteins and structural proteins, which are recognized to stimulate positive immune responses, enhancing both humoral and cellular responses.
Career Highlights
David E. Anderson has made significant strides in the field of biotechnology, particularly through his affiliations with reputable institutions. Notably, he has worked at Variation Biotechnologies Inc., where his research contributions have helped to pave the way for new vaccine technologies. Additionally, he has been associated with Sorbonne Université, further establishing his expertise in the scientific community.
Collaborations
Throughout his career, Anderson has collaborated with talented individuals like Anne-Catherine Fluckiger and Andrei Ogrel. These partnerships have been instrumental in fostering innovative ideas and advancing their shared goals in combating viral infections.
Conclusion
David E. Anderson's contributions to the field of biotechnology through his patents are a testament to his role as an innovative thinker and dedicated researcher. His work not only showcases his expertise but also highlights the importance of collaboration and continued research in addressing global health challenges. As he continues to advance his inventions, the implications of his work promise to have a lasting impact on vaccine development and infectious disease management.